Krane Funds Advisors LLC Invests $398,000 in Maximus, Inc. (NYSE:MMS)

Krane Funds Advisors LLC purchased a new stake in Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,325 shares of the health services provider’s stock, valued at approximately $398,000.

Other hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB acquired a new position in shares of Maximus during the fourth quarter valued at $4,618,000. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock valued at $22,132,000 after acquiring an additional 83,390 shares in the last quarter. IFP Advisors Inc increased its stake in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after acquiring an additional 302 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in Maximus during the 4th quarter valued at $1,113,000. Finally, Legato Capital Management LLC increased its position in shares of Maximus by 33.9% during the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after purchasing an additional 8,138 shares during the period. Institutional investors own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $68.61 on Monday. The company’s fifty day moving average is $69.16 and its two-hundred day moving average is $77.12. The company has a market cap of $3.88 billion, a P/E ratio of 14.76 and a beta of 0.68. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.75%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.